BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

2.90
Delayed Data
As of 3:59pm ET
 +0.08 / +2.84%
Today’s Change
2.49
Today|||52-Week Range
9.95
-64.06%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close2.82
Today’s open2.84
Day’s range2.80 - 3.01
Volume2,322,945
Average volume (3 months)2,159,664
Market cap$342.4M
Data as of 3:59pm ET, 09/19/2019

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)-27.17%
Earnings growth (next 5 years)+19.86%
Revenue growth (last year)-18.00%
P/E ratioNM
Price/Sales40.32
Price/Book6.93

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.08-3.39%
ADMAADMA Biologics Inc-0.04-0.76%
PFNXPfenex Inc-0.14-1.44%
CBMGCellular Biomedicine...-0.08-0.53%
Data as of 6:30pm ET, 09/19/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$20.7M
Annual profit (last year)-$101.3M
Net profit margin-490.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts